New York Life Investment Management LLC Xencor Inc Transaction History

New York Life Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$18.65 - $26.52 $77,043 - $109,554	4,131 Added 33.23%	16,562 $366,000
Q4 2023 Feb 05, 2024	SELL	$16.53 - $21.42 $5,537 - $7,175	-335 Reduced 2.62%	12,431 $263,000
Q3 2023 Nov 07, 2023	SELL	$20.08 - $25.39 $40,380 - $51,059	-2,011 Reduced 13.61%	12,766 $257,000
Q2 2023 Aug 04, 2023	SELL	$24.77 - $29.9 $51,447 - $62,102	-2,077 Reduced 12.32%	14,777 $368,000
Q1 2023 May 08, 2023	SELL	$25.95 - $36.95 $114,309 - $162,764	-4,405 Reduced 20.72%	16,854 $470,000
Q4 2022 Feb 10, 2023	BUY	$24.79 - $30.86 $56,471 - $70,299	2,278 Added 12.0%	21,259 $553,000
Q3 2022 Nov 10, 2022	BUY	$24.62 - $32.44 $36,979 - $48,724	1,502 Added 8.59%	18,981 $493,000
Q2 2022 Aug 12, 2022	BUY	$19.74 - $29.01 $345,035 - $507,065	17,479 New	17,479 $478,000

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.12B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.